Your browser doesn't support javascript.
loading
Real-world efficacy and safety of mobocertinib in EGFR exon 20 insertion-mutated lung cancer.
Kian, Waleed; Christopoulos, Petros; Remilah, Areen A; Levison, Esther; Dudnik, Elizabeth; Shalata, Walid; Krayim, Bilal; Marei, Ranin; Yakobson, Alexander; Faehling, Martin; Kahala, Dolev; Sara Granot, Inbal; Levitas, Dina; Peled, Nir; Roisman, Laila C.
Afiliação
  • Kian W; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.
  • Christopoulos P; Department of Thoracic Oncology, Thoraxklinik at Heidelberg University Hospital, Member of the German Center for Lung Research (DZL), and Translational Lung Research Heidelberg, Heidelberg, Germany.
  • Remilah AA; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.
  • Levison E; Medical School for International Health, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Dudnik E; Thoracic Cancer Service, Assuta Medical Centers, Ben-Gurion University, Tel-Aviv, Israel.
  • Shalata W; The Legacy Heritage Oncology Center and Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel.
  • Krayim B; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.
  • Marei R; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.
  • Yakobson A; The Legacy Heritage Oncology Center and Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel.
  • Faehling M; Department of Pneumology, Esslingen Hospital, Esslingen, Germany.
  • Kahala D; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.
  • Sara Granot I; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.
  • Levitas D; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.
  • Peled N; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.
  • Roisman LC; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.
Front Oncol ; 12: 1010311, 2022.
Article em En | MEDLINE | ID: mdl-36203432
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel